A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

Clinical trial NCT05361174 · RECRUITING

Trial details

NCT number: NCT05361174
Sponsor: Iovance Biotherapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Unresectable Melanoma Metastatic Melanoma Stage III Non-small Cell Lung Cancer Stage IV Non-small Cell Lung Cancer

Start date: 2022-07-20
Primary completion: 2027-09-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.